| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/05/2010 | CN101700251A Donkey-hide gelatin soft capsule |
| 05/05/2010 | CN101700248A Preparation method of Aspirin and Captopril enteric sustained-release capsule |
| 05/05/2010 | CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 05/05/2010 | CN101700246A Compound contraceptive composition, contraceptive transdermal patch containing composition and preparation method |
| 05/05/2010 | CN101700245A Compound drug for curing colds and preparation technology thereof |
| 05/05/2010 | CN101700244A Novel wound paste constructed by water absorption pad of purely natural material |
| 05/05/2010 | CN101700243A Novel medicine carrying woundplast with treating function |
| 05/05/2010 | CN101700242A Steaming-based moxibustion patch |
| 05/05/2010 | CN101700241A Raloxifene emplastrum preparation and preparation method thereof |
| 05/05/2010 | CN101700240A Preparation method of captopril bioadhesive sustained-release capsule |
| 05/05/2010 | CN101700239A Combined capsule filled with glycyrrhizin solid preparation and glycine solid preparation |
| 05/05/2010 | CN101700238A Combined capsule filled with hydrochlorothiazide solid preparation and Benazepril solid preparation |
| 05/05/2010 | CN101700237A Combined capsule filled with hydrochlorothiazide solid preparation and Aliskiren solid preparation |
| 05/05/2010 | CN101700236A Vitamin c soft capsule |
| 05/05/2010 | CN101700235A Self-assembling compound film-controlled slow-release preparation and preparation method thereof |
| 05/05/2010 | CN101700234A Flucloxacillin sodium suspension and new application thereof |
| 05/05/2010 | CN101700233A Method for preparing gonadorelin freeze-dried powder injection |
| 05/05/2010 | CN101700232A Cefprozil submicron emulsion solid preparation and new application thereof |
| 05/05/2010 | CN101700231A Solid preparation comprising pantoprazole sodium submicron emulsion particles |
| 05/05/2010 | CN101700230A Monosialote rahexosylganglioside microsphere and preparing method thereof |
| 05/05/2010 | CN101700229A Prostaglandin E1 long-circulation fat microsphere preparation for intravenous injection and preparation method thereof |
| 05/05/2010 | CN101700228A Preparation method of amino polysaccharide Aspirin composite nanometer particles |
| 05/05/2010 | CN101700227A Matrine colon targeted adhesive pellet and preparation method thereof |
| 05/05/2010 | CN101700226A Naltrexone long-acting sustained-release preparation with no need of coating and preparation method thereof |
| 05/05/2010 | CN101700225A Fat emulsion injection and production method thereof |
| 05/05/2010 | CN101700224A Method for preparing oral chondroitin sulfate nanoemulsion |
| 05/05/2010 | CN101700223A Erythromycin cydocarbonate injection and preparation process thereof |
| 05/05/2010 | CN101700222A Oridonin solid dispersion preparation |
| 05/05/2010 | CN101700221A Process for preparing targeting fat-reducing calcium-supplying oral liquid enriched with lecithin-calcium acetate coupled material by lipidosome biotechnology |
| 05/05/2010 | CN101700216A Natural aromatic water, preparation method thereof and application |
| 05/05/2010 | CN101700213A Facial mask for removing color flecks |
| 05/05/2010 | CN101065120B 4-hydroxy tamoxifen gel formulations |
| 05/05/2010 | CN101035550B Composition and method for therapy or prevention of mental symptom |
| 05/05/2010 | CN101023119B Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 05/04/2010 | US7709536 Pharmaceutical formulation |
| 05/04/2010 | US7709529 Treatment of cancer with glutamine |
| 05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
| 05/04/2010 | US7709464 Drud delivery; prolonging the time a pharmaceutical drug circulates in the blood of a subject by using a liposome containing the inventive compound as a carrier |
| 05/04/2010 | US7709462 Implantable and biocompatible gellable composition |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709457 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 05/04/2010 | US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/04/2010 | US7709445 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 05/04/2010 | US7709444 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 05/04/2010 | US7709028 Particulate product comprising pantethine |
| 05/04/2010 | US7709027 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 05/04/2010 | US7709026 Synergistic mixture reducing pH, adjustment oxygen concentration containing peroxy compound and bioadhesive |
| 05/04/2010 | US7709025 Enteric film coatings of a dispersion of ethylcellulose particlesand a gastro-insoluble pore former such as sodium alginate; substrate is substantially insoluble in a medium of 0.1 N HCl for one hour; drugs; food additives; nutrients |
| 05/04/2010 | US7709024 1-(8-{4-[3-(5-Fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one (SLV 314); coated tablet comprising compressed comprises hypromellose, microcrystalline cellulose, and lubricant; G protein coupled receptor inhibitors; solubility, stability and ease of formulation |
| 05/04/2010 | US7709023 Quick dissolve compositions and tablets based thereon |
| 05/04/2010 | US7709022 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 05/04/2010 | US7709021 Microbial cellulose wound dressing for treating chronic wounds |
| 05/04/2010 | US7709019 Employing biodegradable barrier having binding member that couples with cells or organ surface to hinder diffusion; sustained release, lower dosage |
| 05/04/2010 | US7709018 Composite structures containing hyaluronic acid the derivatives thereof as new bone substitutes and grafts |
| 05/04/2010 | US7709017 Biocompatible, biodegradable globins modified by acetylation, succinylationor esterification; soluble at physioloical pH; grafting; powder, granules, film, membrane, mesh, sponge and preformed implant, or in paste, gel, or suspension form; prosthetics |
| 05/04/2010 | US7709012 Ophthalmic compositions containing a synergistic combination of two polymers |
| 05/04/2010 | US7709011 Cosmetic or pharmaceutical preparations comprising an oxalkylated polyglycerol ester |
| 05/04/2010 | US7709005 Applying to the skin a composition comprising a hydrophilic foam substrate and a hydrophilic agent capable of absorbing water and a wetting agent; polyurethanes, superabsorbent polymers; surfactants; drug delivery;antiinflammatory agents; antiswelling agents; antinociceptive agents;analgesics |
| 05/04/2010 | US7708989 Administering nitrosated angiotensin converting enzyme inhibitors and other nitrosated compounds for cardiovascular disorders and treatment of hypertensive agents |
| 05/04/2010 | US7708988 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/04/2010 | US7708980 Nonflammable propellant blend |
| 05/04/2010 | US7708873 Induced-charge electro-osmotic microfluidic devices |
| 05/04/2010 | US7708871 for controlling the flow of charged particles in an electrolyte; apparatus comprises an electrolytic bath container divided by a polymeric membrane foil into first and second compartments, wherein each compartment comprises an electrode connected to voltage supply |
| 05/04/2010 | US7708784 Prosthetic foot with tunable performance |
| 05/04/2010 | US7708717 Operating an infusion pump system |
| 05/04/2010 | US7707970 immunogens |
| 05/04/2010 | US7707964 Pharmaceutical dispensing apparatus and method |
| 05/04/2010 | CA2634654C Reagent compositions for analytical testing |
| 05/04/2010 | CA2476587C Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/04/2010 | CA2463896C Injectable compositions for the controlled delivery of pharmacologically active compound |
| 05/04/2010 | CA2459317C Infusion device and driving mechanism for same |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2436554C Condom with male genital desensitizer lubricant |
| 05/04/2010 | CA2431519C Topical composition and method for treating urinary stress incontinence |
| 05/04/2010 | CA2427385C Nutritional composition for an immune condition |
| 05/04/2010 | CA2417646C Topical gel delivery system |
| 05/04/2010 | CA2378438C Methods for preparation of lipid-encapsulated therapeutic agents |
| 05/04/2010 | CA2375083C Clear oil-containing pharmaceutical compositions |
| 05/04/2010 | CA2352484C Pressurised metered dose inhalers (mdi) |
| 05/04/2010 | CA2347981C Process for the manufacturing of alkaline salts of substituted sulphinyl compounds and products prepared thereby |
| 05/04/2010 | CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use |
| 05/04/2010 | CA2282439C Formulations for hydrophobic pharmaceutical agents |
| 04/29/2010 | WO2010048623A2 Medical and imaging nanoclusters |
| 04/29/2010 | WO2010048610A2 Compositions and methods for promoting bone formation |
| 04/29/2010 | WO2010048593A1 Compositions comprising 4- (2- ( 5-br0m0-4- ( l-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triazol-3-ylthio) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 04/29/2010 | WO2010048592A1 Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 04/29/2010 | WO2010048478A2 Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates |
| 04/29/2010 | WO2010048389A2 Pharmaceutical pellets comprising modified starch and therapeutic applications therefor |
| 04/29/2010 | WO2010048281A1 Composite biomimetic materials |
| 04/29/2010 | WO2010048250A2 Anhydrous antiperspirant compositions |
| 04/29/2010 | WO2010048154A2 Structured composition comprising an encapsulated active |
| 04/29/2010 | WO2010048095A2 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 04/29/2010 | WO2010048086A1 Drug delivery systems and methods for treating neovascularization |
| 04/29/2010 | WO2010048064A2 Drug delivery system and its use in the treatment of postherpetic neuralgia |
| 04/29/2010 | WO2010048028A2 Apparatus for preparing a sterile composition |
| 04/29/2010 | WO2010047826A2 Dosing regimens and dosage formulations of an antiviral peptide therapeutic |
| 04/29/2010 | WO2010047765A2 Nanostructures for drug delivery |
| 04/29/2010 | WO2010047756A1 Oral dosage forms including an antiplatelet agents and an enterically coated acid inhibitor |
| 04/29/2010 | WO2010047669A1 "cholvacor" - a medication in the form of liquid used for regulation of lipid exchange |